ARVIDAL Logo (WIPO, 12/11/2020)
WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark ARVIDAL was filed as Figurative mark on 12/11/2020 at the World Intellectual Property Organization.
| Trademark form | Figurative mark |
| File reference | 1582408 |
| Countries | 
|
| Base trademark |
No. 40202023670S,
November 12, 2020
|
| Application date | December 11, 2020 |
| Expiration date | December 11, 2030 |
Trademark owner
1 COLEMAN STREET,
#10-06 THE ADELPHI
SG
#10-06 THE ADELPHI
SG
Trademark representatives
1 PAYA LEBAR LINK,
#06-08 PLQ2,
SG
goods and services
05
Pharmaceutical preparations; pharmaceutical preparations and
pharmaceutical products for the prevention, and treatment of
infections or diseases caused by viruses; pharmaceutical
preparations and pharmaceutical products for the prevention,
and treatment of infections or diseases caused by viruses,
namely by intravenous, intramuscular, oral, sublingual,
buccal, nasal, topical administration and/or administered by
inhalation, by spraying or by nebulisation in patients;
pharmaceutical preparations and pharmaceutical products for
the prevention, and treatment of infections caused by
viruses, seasonal and pandemic influenza A and B viruses,
seasonal coronaviruses (Alpha-, Beta-, Gamma- and
Deltacoronaviruses), severe acute respiratory syndrome
(SARS-CoV) coronaviruses and Middle East respiratory
syndrome (MERS) coronavirus, adenoviruses, respiratory
syncytial viruses, parainfluenza viruses, rhinoviruses,
human metapneumoviruses, bocaviruses, and infections of
combined etiology (multiple viral infections);
pharmaceutical preparations and pharmaceutical products for
the prevention, and treatment of infections caused by viral
infections of the upper and lower respiratory tract;
pharmaceutical preparations and pharmaceutical products for
the prevention, and treatment of acute respiratory
infections caused by viral infections of the upper and lower
respiratory tract; pharmaceutical preparations and
pharmaceutical products for the prevention and treatment of
tissue lesions in the lungs caused by severe pulmonary
infectious diseases; pharmaceutical preparations and
pharmaceutical products for the prevention and treatment of
complications arising from or caused by viral infections;
pharmaceutical preparations and pharmaceutical products for
the prevention and treatment of acute respiratory
infections, acute respiratory viral infections of unknown
origins and complications arising from or caused by viral
infections
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| March 14, 2023 | 2023/11 Gaz | US | Rejection |
| December 14, 2022 | 2022/52 Gaz | TH | Rejection |
| October 13, 2022 | 2022/41 Gaz | MY | Rejection |
| August 29, 2022 | 2022/41 Gaz | IN | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| July 12, 2022 | 2022/28 Gaz | CA | Rejection |
| June 13, 2022 | 2022/24 Gaz | MX | Rejection |
| May 19, 2022 | 2022/20 Gaz | KR | Rejection |
| May 17, 2022 | 2022/20 Gaz | SE | Rejection |
| March 25, 2022 | 2022/13 Gaz | AM | Rejection |
| March 24, 2022 | 2022/12 Gaz | VN | Rejection |
| March 3, 2022 | 2022/9 Gaz | GR | Rejection |
| March 2, 2022 | 2022/12 Gaz | IL | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| March 1, 2022 | 2022/9 Gaz | MD | Rejection |
| February 17, 2022 | 2022/7 Gaz | CH | Rejection |
| February 15, 2022 | 2022/7 Gaz | IT | Rejection |
| February 10, 2022 | 2022/6 Gaz | NO | Rejection |
| February 8, 2022 | 2022/6 Gaz | ID | Rejection |
| February 7, 2022 | 2022/6 Gaz | KZ | Rejection |
| February 4, 2022 | 2022/6 Gaz | SI | Rejection |
| January 27, 2022 | 2022/4 Gaz | JP | Rejection |
| January 24, 2022 | 2022/4 Gaz | UA | Rejection |
| January 18, 2022 | 2022/3 Gaz | BR | Rejection |
| January 5, 2022 | 2022/1 Gaz | TR | Rejection |
| January 5, 2022 | 2022/1 Gaz | BG | Rejection |
| December 22, 2021 | 2021/51 Gaz | GB | Rejection |
| November 30, 2021 | 2021/48 Gaz | KG | Rejection |
| November 16, 2021 | 2021/47 Gaz | US | Rejection |
| October 22, 2021 | 2021/43 Gaz | PT | Rejection |
| October 21, 2021 | 2021/42 Gaz | HU | Rejection |
| October 18, 2021 | 2021/45 Gaz | PH | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| September 30, 2021 | 2021/39 Gaz | RO | Rejection |
| September 17, 2021 | 2021/38 Gaz | RS | Rejection |
| September 16, 2021 | 2021/38 Gaz | FR | Rejection |
| September 2, 2021 | 2021/36 Gaz | BY | Rejection |
| August 11, 2021 | 2021/33 Gaz | SE | Rejection |
| August 10, 2021 | 2021/32 Gaz | BX | Rejection |
| August 2, 2021 | 2021/31 Gaz | CZ | Rejection |
| July 30, 2021 | 2021/30 Gaz | SK | Rejection |
| July 29, 2021 | 2021/30 Gaz | PL | Rejection |
| July 29, 2021 | 2021/30 Gaz | DE | Rejection |
| July 19, 2021 | 2021/30 Gaz | IL | Rejection |
| July 13, 2021 | 2021/28 Gaz | ES | Rejection |
| July 12, 2021 | 2021/28 Gaz | AT | Rejection |
| July 5, 2021 | 2021/27 Gaz | CN | Rejection |
| July 2, 2021 | 2021/27 Gaz | US | Rejection |
| June 23, 2021 | 2021/25 Gaz | FI | Rejection |
| June 23, 2021 | 2021/25 Gaz | AU | Rejection |
| May 3, 2021 | 2021/20 Gaz | PH | Rejection |
| April 19, 2021 | 2021/17 Gaz | IN | Rejection |
| December 11, 2020 | SG | Registration |
ID: 141582408